speb/financial-data huggingface dataset:
IBG.MC balance_sheet (quarterly, 2024-12-31) — Finished Goods: 24480000.00
IBG.MC cash_flow (annual, 2024-12-31) — Free Cash Flow: 34185000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 7996000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 7996000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 33858000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 33858000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Gross PPE: 437260000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Gross PPE: 437260000.00
IBG.MC income_statement (annual, 2024-12-31) — Gross Profit: 147123000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Gross Profit: 40807000.00
IBG.MC income_statement (annual, 2024-12-31) — Interest Expense: 245000.00
IBG.MC income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 245000.00
IBG.MC income_statement (annual, 2024-12-31) — Interest Income: 4644000.00
IBG.MC income_statement (annual, 2024-12-31) — Interest Income Non Operating: 4644000.00
IBG.MC cash_flow (annual, 2024-12-31) — Interest Received Cfo: 4256000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Inventory: 35153000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Inventory: 35153000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Invested Capital: 358044000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Invested Capital: 358044000.00
IBG.MC cash_flow (annual, 2024-12-31) — Investing Cash Flow: -14830000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 59000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 59000.00
IBG.MC cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 36000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Long Term Debt: 12451000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 12451000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 12451000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 12451000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Long Term Provisions: 130000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 130000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 385460000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 385460000.00
IBG.MC cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 36000.00
IBG.MC cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -180000.00
IBG.MC income_statement (annual, 2024-12-31) — Net Income: 23161000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Net Income: 7610000.00
IBG.MC income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 23161000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 7610000.00
IBG.MC income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 23161000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 7610000.00
IBG.MC income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 23161000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 7610000.00
IBG.MC income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 23161000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 7610000.00
IBG.MC cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 28562000.00
IBG.MC income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 23161000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 7610000.00
IBG.MC cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -318000.00
IBG.MC income_statement (annual, 2024-12-31) — Net Interest Income: 3459000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Net Interest Income: -2285000.00
IBG.MC cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -7580000.00
IBG.MC income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 3459000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -2285000.00
IBG.MC cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -7607000.00
IBG.MC cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -7580000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Net PPE: 160501000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Net PPE: 160501000.00
IBG.MC cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -7250000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 331622000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 331622000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 4232000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 4232000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 484000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 484000.00
IBG.MC income_statement (annual, 2024-12-31) — Normalized EBITDA: 38327000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 20537000.00
IBG.MC income_statement (annual, 2024-12-31) — Normalized Income: 23161000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Normalized Income: 8393859.27
IBG.MC cash_flow (annual, 2024-12-31) — Operating Cash Flow: 41435000.00
IBG.MC income_statement (annual, 2024-12-31) — Operating Income: 25103000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Operating Income: 11194000.00
IBG.MC income_statement (annual, 2024-12-31) — Operating Revenue: 238189000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Operating Revenue: 56718000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 10900992.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 10900992.00
IBG.MC balance_sheet (annual, 2024-12-31) — Other Current Assets: 17425000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 17425000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 7996000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 7996000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Other Inventories: 655000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Other Inventories: 655000.00
IBG.MC cash_flow (annual, 2024-12-31) — Other Non Cash Items: -8853000.00
IBG.MC income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1237000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -3121000.00
IBG.MC income_statement (annual, 2024-12-31) — Other Operating Expenses: 92912000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 27245000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Other Payable: 7109000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Other Payable: 7109000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Other Properties: 2759000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Other Properties: 2759000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Other Receivables: 4499000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Other Receivables: 4499000.00
IBG.MC income_statement (annual, 2024-12-31) — Other Special Charges: 976000.00
IBG.MC income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
IBG.MC income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
IBG.MC balance_sheet (annual, 2024-12-31) — Payables: 39468000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Payables: 39468000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Prepaid Assets: 686000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 686000.00
IBG.MC income_statement (annual, 2024-12-31) — Pretax Income: 28562000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Pretax Income: 9621000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Properties: 48089000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Properties: 48089000.00
IBG.MC cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 11423000.00
IBG.MC cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -318000.00
IBG.MC cash_flow (annual, 2024-12-31) — Purchase Of PPE: -7250000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Raw Materials: 9774000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Raw Materials: 9774000.00
IBG.MC income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 91066000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 15911000.00
IBG.MC income_statement (annual, 2024-12-31) — Reconciled Depreciation: 13224000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 3411000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Retained Earnings: 341258000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 341258000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Share Issued: 10964445.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Share Issued: 10964445.00
IBG.MC income_statement (annual, 2024-12-31) — Special Income Charges: -976000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Special Income Charges: -991000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Stockholders Equity: 339618000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 339618000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Tangible Book Value: 331622000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 331622000.00
IBG.MC income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IBG.MC income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -207140.73
IBG.MC income_statement (annual, 2024-12-31) — Tax Provision: 5401000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Tax Provision: 2011000.00
IBG.MC income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.19
IBG.MC income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.21
IBG.MC cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -5658000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Total Assets: 407679000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Total Assets: 407679000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Total Capitalization: 352069000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 352069000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Total Debt: 18426000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Total Debt: 18426000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 339618000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 339618000.00
IBG.MC income_statement (annual, 2024-12-31) — Total Expenses: 213086000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Total Expenses: 45524000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 68061000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 68061000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 195034000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 195034000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 15166000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 15166000.00
IBG.MC income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 25103000.00
IBG.MC income_statement (annual, 2024-12-31) — Total Other Finance Cost: 144000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2489000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 2489000.00
IBG.MC income_statement (annual, 2024-12-31) — Total Unusual Items: -976000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Total Unusual Items: -991000.00
IBG.MC income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -976000.00
IBG.MC income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -991000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 63453.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 63453.00
IBG.MC balance_sheet (annual, 2024-12-31) — Treasury Stock: 1081000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 1081000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Work In Process: 244000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Work In Process: 244000.00
IBG.MC balance_sheet (annual, 2024-12-31) — Working Capital: 159750000.00
IBG.MC balance_sheet (quarterly, 2024-12-31) — Working Capital: 159750000.00
IBG.MC income_statement (quarterly, 2025-03-31) — +Operating Expense: 9425000.00
IBG.MC income_statement (quarterly, 2025-03-31) — +Total Revenue: 65825000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 40001000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 59452000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 8291000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Basic Average Shares: 10900992.00
IBG.MC income_statement (quarterly, 2025-03-31) — Basic EPS: 0.10
IBG.MC balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6579000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 123635000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 123635000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Common Stock: 6579000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 340651000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 28895000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Current Assets: 215282000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Current Debt: 6063000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6063000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 55477000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Current Provisions: 9413000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 3350000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 3350000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 10900992.00
IBG.MC income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.10
IBG.MC income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1101000.00
IBG.MC income_statement (quarterly, 2025-03-31) — EBIT: 27505000.00
IBG.MC income_statement (quarterly, 2025-03-31) — EBITDA: 30855000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 13914000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Gross Profit: 36930000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Inventory: 32195000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Invested Capital: 357780000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 6205000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 11066000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 11066000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 268000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Net Income: 1101000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1101000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1101000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1101000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1101000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1101000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Net Interest Income: 518000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 518000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Net PPE: 157708000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 326737000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 4175000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 485000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 30855000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Normalized Income: 1101000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Operating Income: 27505000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Operating Revenue: 65825000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 10900992.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 13914000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 5191000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -26572000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Payables: 40001000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Pretax Income: 1451000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 28895000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3350000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 342261000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Share Issued: 10964445.00
IBG.MC income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 340651000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 326737000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IBG.MC income_statement (quarterly, 2025-03-31) — Tax Provision: 350000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
IBG.MC balance_sheet (quarterly, 2025-03-31) — Total Assets: 413138000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 351717000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Total Debt: 17129000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 340651000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Total Expenses: 38320000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 72487000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 197856000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 17010000.00
IBG.MC income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
IBG.MC income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 63453.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 1071000.00
IBG.MC balance_sheet (quarterly, 2025-03-31) — Working Capital: 159805000.00
IBG.MC income_statement (quarterly, 2025-06-30) — +Operating Expense: 57309000.00
IBG.MC income_statement (quarterly, 2025-06-30) — +Total Revenue: 50385000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 38028000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 33660000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2839000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -1030000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Capital Stock: 6579000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 78628000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 78628000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 78628000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Common Stock: 6579000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 333853000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 18960000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Current Assets: 209615000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Current Debt: 6070000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 6070000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 57428000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Current Provisions: 10840000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 3520000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 3520000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1129000.00
IBG.MC income_statement (quarterly, 2025-06-30) — EBIT: -24467000.00
IBG.MC income_statement (quarterly, 2025-06-30) — EBITDA: -20947000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Finished Goods: 22984000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 14605000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 34690000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Gross Profit: 31425000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Inventory: 36583000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Invested Capital: 349600000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 6265000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 9677000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 9677000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 168000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Net Income: 1129000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1129000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1129000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1129000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1129000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1129000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Net Interest Income: -659000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -659000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Net PPE: 156415000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 319248000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 4073000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 359000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -20471000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Normalized Income: 1485368.70
IBG.MC income_statement (quarterly, 2025-06-30) — Operating Income: -25884000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Operating Revenue: 50385000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 10901475.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 55609000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 14605000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Other Inventories: 1261000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 4040000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 27013000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Other Receivables: 5135000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Payables: 40518000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Pretax Income: 1508000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Raw Materials: 12085000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 18960000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3520000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 338025000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Share Issued: 10900992.00
IBG.MC income_statement (quarterly, 2025-06-30) — Special Income Charges: -476000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 333853000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 319248000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -119631.30
IBG.MC income_statement (quarterly, 2025-06-30) — Tax Provision: 379000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
IBG.MC balance_sheet (quarterly, 2025-06-30) — Total Assets: 405525000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 343530000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Total Debt: 15747000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 333853000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Total Expenses: 76269000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 71672000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 195910000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 14244000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 2490000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Total Unusual Items: -476000.00
IBG.MC income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -476000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 62970.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 1071000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Work In Process: 253000.00
IBG.MC balance_sheet (quarterly, 2025-06-30) — Working Capital: 152187000.00
IBG.MC income_statement (annual, 2025-12-31) — +Operating Expense: 123747000.00
IBG.MC income_statement (annual, 2025-12-31) — +Total Revenue: 216735000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Accounts Payable: 32915000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Accounts Receivable: 37307000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2839000.00
IBG.MC income_statement (annual, 2025-12-31) — Basic Average Shares: 10821429.00
IBG.MC income_statement (annual, 2025-12-31) — Basic EPS: 0.56
IBG.MC cash_flow (annual, 2025-12-31) — Beginning Cash Position: 122082000.00
IBG.MC cash_flow (annual, 2025-12-31) — Capital Expenditure: -15028000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Capital Stock: 6579000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 127603000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 127603000.00
IBG.MC cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -10140000.00
IBG.MC cash_flow (annual, 2025-12-31) — Changes In Cash: 5786000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Common Stock: 6579000.00
IBG.MC cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -10140000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Common Stock Equity: 332085000.00
IBG.MC cash_flow (annual, 2025-12-31) — Common Stock Issuance: 14000.00
IBG.MC income_statement (annual, 2025-12-31) — Cost Of Revenue: 87260000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Current Assets: 202580000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Current Debt: 6146000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6146000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Current Liabilities: 46989000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Current Provisions: 7928000.00
IBG.MC cash_flow (annual, 2025-12-31) — Depreciation: 14608000.00
IBG.MC cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 14608000.00
IBG.MC income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 14608000.00
IBG.MC income_statement (annual, 2025-12-31) — Depreciation Income Statement: 14608000.00
IBG.MC income_statement (annual, 2025-12-31) — Diluted Average Shares: 10821429.00
IBG.MC income_statement (annual, 2025-12-31) — Diluted EPS: 0.56
IBG.MC income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 6060000.00
IBG.MC income_statement (annual, 2025-12-31) — EBIT: 5728000.00
IBG.MC income_statement (annual, 2025-12-31) — EBITDA: 20336000.00
IBG.MC cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -265000.00
IBG.MC cash_flow (annual, 2025-12-31) — End Cash Position: 127603000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 5788000.00
IBG.MC cash_flow (annual, 2025-12-31) — Financing Cash Flow: -15513000.00
IBG.MC cash_flow (annual, 2025-12-31) — Free Cash Flow: 3904000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 6479000.00
IBG.MC income_statement (annual, 2025-12-31) — Gross Profit: 129475000.00
IBG.MC cash_flow (annual, 2025-12-31) — Interest Received Cfo: 2841000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Inventory: 37670000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Invested Capital: 345123000.00
IBG.MC cash_flow (annual, 2025-12-31) — Investing Cash Flow: 2367000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 5788000.00
IBG.MC cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 14000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Long Term Debt: 6892000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6892000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Long Term Provisions: 36000.00
IBG.MC cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 14000.00
IBG.MC income_statement (annual, 2025-12-31) — Net Income: 6060000.00
IBG.MC income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 6060000.00
IBG.MC income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 6060000.00
IBG.MC income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6060000.00
IBG.MC income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6060000.00
IBG.MC cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 7826000.00
IBG.MC income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 6060000.00
IBG.MC income_statement (annual, 2025-12-31) — Net Interest Income: 2098000.00
IBG.MC income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 2098000.00
IBG.MC cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -5387000.00
IBG.MC cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 17395000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Net PPE: 155499000.00
IBG.MC cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -15028000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 325606000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 4026000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 411000.00
IBG.MC income_statement (annual, 2025-12-31) — Normalized EBITDA: 20336000.00
IBG.MC income_statement (annual, 2025-12-31) — Normalized Income: 6060000.00
IBG.MC cash_flow (annual, 2025-12-31) — Operating Cash Flow: 18932000.00
IBG.MC income_statement (annual, 2025-12-31) — Operating Income: 5728000.00
IBG.MC income_statement (annual, 2025-12-31) — Operating Revenue: 216735000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 10901475.00
IBG.MC balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 6479000.00
IBG.MC income_statement (annual, 2025-12-31) — Other Operating Expenses: 96978000.00
IBG.MC income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
IBG.MC balance_sheet (annual, 2025-12-31) — Payables: 32915000.00
IBG.MC income_statement (annual, 2025-12-31) — Pretax Income: 7826000.00
IBG.MC cash_flow (annual, 2025-12-31) — Purchase Of PPE: -15028000.00
IBG.MC income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 87260000.00
IBG.MC income_statement (annual, 2025-12-31) — Reconciled Depreciation: 14608000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Retained Earnings: 6060000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Share Issued: 10901475.00
IBG.MC balance_sheet (annual, 2025-12-31) — Stockholders Equity: 332085000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Tangible Book Value: 325606000.00
IBG.MC income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IBG.MC income_statement (annual, 2025-12-31) — Tax Provision: 1766000.00
IBG.MC income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.23
IBG.MC cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -3773000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Total Assets: 389074000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Total Capitalization: 338977000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Total Debt: 13038000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 332085000.00
IBG.MC income_statement (annual, 2025-12-31) — Total Expenses: 211007000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 56989000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 186494000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10000000.00
IBG.MC income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 5728000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Treasury Stock: 1067000.00
IBG.MC balance_sheet (annual, 2025-12-31) — Working Capital: 155591000.00
IBIO balance_sheet (annual, 2021-06-30) — Accounts Receivable: 426000.00
IBIO cash_flow (annual, 2021-06-30) — Amortization Of Securities: 216000.00
IBIO cash_flow (annual, 2021-06-30) — Change In Inventory: 772000.00
IBIO cash_flow (annual, 2021-06-30) — Change In Receivables: -10738000.00
IBIO cash_flow (annual, 2021-06-30) — Changes In Account Receivables: -426000.00
IBIO balance_sheet (annual, 2021-06-30) — Construction In Progress: 3367000.00
IBIO income_statement (annual, 2021-06-30) — Cost Of Revenue: 1462000.00
IBIO balance_sheet (annual, 2021-06-30) — Current Notes Payable: 0.00
IBIO cash_flow (annual, 2021-06-30) — Effect Of Exchange Rate Changes: -1000.00
IBIO balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: -63000.00
IBIO income_statement (annual, 2021-06-30) — Gross Profit: 909000.00
IBIO balance_sheet (annual, 2021-06-30) — Interest Payable: 406000.00
IBIO balance_sheet (annual, 2021-06-30) — Inventory: 27000.00
IBIO balance_sheet (annual, 2021-06-30) — Minority Interest: -17000.00
IBIO income_statement (annual, 2021-06-30) — Minority Interests: 6000.00
IBIO cash_flow (annual, 2021-06-30) — Net Investment Purchase And Sale: -19816000.00
IBIO cash_flow (annual, 2021-06-30) — Net Other Investing Changes: -1500000.00
IBIO cash_flow (annual, 2021-06-30) — Net Preferred Stock Issuance: 78276000.00
IBIO balance_sheet (annual, 2021-06-30) — Non Current Accounts Receivable: 5100000.00
IBIO cash_flow (annual, 2021-06-30) — Operating Gains Losses: 143000.00
IBIO balance_sheet (annual, 2021-06-30) — Other Current Borrowings: 600000.00
IBIO balance_sheet (annual, 2021-06-30) — Other Equity Adjustments: -63000.00
IBIO income_statement (annual, 2021-06-30) — Other Income Expense: 10212000.00
IBIO income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 12000.00
IBIO balance_sheet (annual, 2021-06-30) — Other Receivables: 5100000.00
IBIO balance_sheet (annual, 2021-06-30) — Other Short Term Investments: 19570000.00
IBIO income_statement (annual, 2021-06-30) — Other Special Charges: -10200000.00
IBIO income_statement (annual, 2021-06-30) — Preferred Stock Dividends: 260000.00
IBIO cash_flow (annual, 2021-06-30) — Preferred Stock Issuance: 78276000.00
IBIO balance_sheet (annual, 2021-06-30) — Prepaid Assets: 2070000.00
IBIO cash_flow (annual, 2021-06-30) — Purchase Of Intangibles: -242000.00
IBIO cash_flow (annual, 2021-06-30) — Purchase Of Investment: -23816000.00
IBIO balance_sheet (annual, 2021-06-30) — Raw Materials: 0.00
IBIO income_statement (annual, 2021-06-30) — Reconciled Cost Of Revenue: 1462000.00
IBIO cash_flow (annual, 2021-06-30) — Sale Of Investment: 4000000.00
IBIO balance_sheet (annual, 2021-06-30) — Total Tax Payable: 295000.00
IBIO balance_sheet (annual, 2021-06-30) — Work In Process: 27000.00
IBIO income_statement (annual, 2022-06-30) — +Operating Expense: 31581000.00
IBIO income_statement (annual, 2022-06-30) — +Total Revenue: 343482.22
IBIO balance_sheet (annual, 2022-06-30) — Accounts Payable: 4264000.00
IBIO balance_sheet (annual, 2022-06-30) — Accounts Receivable: 1000000.00
IBIO balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 287619000.00
IBIO cash_flow (annual, 2022-06-30) — Amortization Cash Flow: 401000.00
IBIO cash_flow (annual, 2022-06-30) — Amortization Of Intangibles: 401000.00
IBIO cash_flow (annual, 2022-06-30) — Amortization Of Securities: 312000.00
IBIO cash_flow (annual, 2022-06-30) — Asset Impairment Charge: 1760000.00
IBIO balance_sheet (annual, 2022-06-30) — Assets Held For Sale Current: 3900000.00
IBIO income_statement (annual, 2022-06-30) — Basic Average Shares: 436050.00
IBIO income_statement (annual, 2022-06-30) — Basic EPS: -115.60
IBIO cash_flow (annual, 2022-06-30) — Beginning Cash Position: 77404000.00
IBIO balance_sheet (annual, 2022-06-30) — Buildings And Improvements: 0.00
IBIO cash_flow (annual, 2022-06-30) — Capital Expenditure: -11630000.00
IBIO balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 3605000.00
IBIO balance_sheet (annual, 2022-06-30) — Capital Stock: 9000.00
IBIO balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 22676000.00
IBIO balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 33521000.00
IBIO cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: -6125000.00
IBIO cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -5127000.00
IBIO cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: -37480000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Account Payable: 1239000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Accrued Expense: 1443000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Inventory: -3873000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Other Current Liabilities: -15000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Other Working Capital: 7000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Payable: 1239000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Payables And Accrued Expense: 2682000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Prepaid Assets: 228000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Receivables: 4214000.00
IBIO cash_flow (annual, 2022-06-30) — Change In Working Capital: 3243000.00
IBIO cash_flow (annual, 2022-06-30) — Changes In Account Receivables: -886000.00
IBIO cash_flow (annual, 2022-06-30) — Changes In Cash: -48732000.00
IBIO balance_sheet (annual, 2022-06-30) — Common Stock: 9000.00
IBIO balance_sheet (annual, 2022-06-30) — Common Stock Equity: 63485000.00
IBIO cash_flow (annual, 2022-06-30) — Common Stock Issuance: 0.00
IBIO cash_flow (annual, 2022-06-30) — Common Stock Payments: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Construction In Progress: 1373000.00
IBIO income_statement (annual, 2022-06-30) — Cost Of Revenue: 216000.00
IBIO balance_sheet (annual, 2022-06-30) — Current Accrued Expenses: 3480000.00
IBIO balance_sheet (annual, 2022-06-30) — Current Assets: 45070000.00
IBIO balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 91000.00
IBIO balance_sheet (annual, 2022-06-30) — Current Debt: 22161000.00
IBIO balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 22252000.00
IBIO balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 100000.00
IBIO balance_sheet (annual, 2022-06-30) — Current Deferred Revenue: 100000.00
IBIO balance_sheet (annual, 2022-06-30) — Current Liabilities: 30436000.00
IBIO balance_sheet (annual, 2022-06-30) — Current Notes Payable: 22161000.00
IBIO cash_flow (annual, 2022-06-30) — Depreciation: 3390000.00
IBIO cash_flow (annual, 2022-06-30) — Depreciation Amortization Depletion: 3791000.00
IBIO cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 3791000.00
IBIO income_statement (annual, 2022-06-30) — Diluted Average Shares: 436050.00
IBIO income_statement (annual, 2022-06-30) — Diluted EPS: -115.60
IBIO income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: -50391000.00
IBIO income_statement (annual, 2022-06-30) — EBIT: -29513000.00
IBIO income_statement (annual, 2022-06-30) — EBITDA: -25722000.00
IBIO cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: 0.00
IBIO cash_flow (annual, 2022-06-30) — End Cash Position: 28672000.00
IBIO cash_flow (annual, 2022-06-30) — Financing Cash Flow: -6125000.00
IBIO cash_flow (annual, 2022-06-30) — Free Cash Flow: -49110000.00
IBIO cash_flow (annual, 2022-06-30) — Gain Loss On Sale Of PPE: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: -213000.00
IBIO income_statement (annual, 2022-06-30) — General And Administrative Expense: 21754000.00
IBIO balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 4851000.00
IBIO balance_sheet (annual, 2022-06-30) — Gross PPE: 4441000.00
IBIO income_statement (annual, 2022-06-30) — Gross Profit: 127482.22
IBIO income_statement (annual, 2022-06-30) — Interest Expense: 0.00
IBIO income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 0.00
IBIO income_statement (annual, 2022-06-30) — Interest Income: 177000.00
IBIO income_statement (annual, 2022-06-30) — Interest Income Non Operating: 177000.00
IBIO cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 1045000.00
IBIO balance_sheet (annual, 2022-06-30) — Interest Payable: 59000.00
IBIO balance_sheet (annual, 2022-06-30) — Inventory: 3900000.00
IBIO balance_sheet (annual, 2022-06-30) — Invested Capital: 85646000.00
IBIO cash_flow (annual, 2022-06-30) — Investing Cash Flow: -5127000.00
IBIO cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 0.00
IBIO cash_flow (annual, 2022-06-30) — Issuance Of Debt: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Liabilities Heldfor Sale Non Current: 1971000.00
IBIO balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 3514000.00
IBIO balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 3514000.00
IBIO cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 0.00
IBIO cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -5830000.00
IBIO balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Minority Interest: 0.00
IBIO income_statement (annual, 2022-06-30) — Minority Interests: 1000.00
IBIO cash_flow (annual, 2022-06-30) — Net Business Purchase And Sale: 0.00
IBIO cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 0.00
IBIO income_statement (annual, 2022-06-30) — Net Income: -50391000.00
IBIO income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -50391000.00
IBIO income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -29513000.00
IBIO income_statement (annual, 2022-06-30) — Net Income Discontinuous Operations: -20791000.00
IBIO income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -50303000.00
IBIO income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -29512000.00
IBIO cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: -50304000.00
IBIO income_statement (annual, 2022-06-30) — Net Income From Tax Loss Carryforward: -88000.00
IBIO income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -50392000.00
IBIO cash_flow (annual, 2022-06-30) — Net Intangibles Purchase And Sale: -4300000.00
IBIO income_statement (annual, 2022-06-30) — Net Interest Income: 177000.00
IBIO cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: 6503000.00
IBIO cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -5830000.00
IBIO cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -5830000.00
IBIO income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: 177000.00
IBIO cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -372000.00
IBIO balance_sheet (annual, 2022-06-30) — Net PPE: 4441000.00
IBIO cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -7330000.00
IBIO cash_flow (annual, 2022-06-30) — Net Preferred Stock Issuance: 0.00
IBIO cash_flow (annual, 2022-06-30) — Net Short Term Debt Issuance: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 58634000.00
IBIO balance_sheet (annual, 2022-06-30) — Non Current Accrued Expenses: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Non Current Note Receivables: 1631000.00
IBIO balance_sheet (annual, 2022-06-30) — Non Current Prepaid Assets: 103000.00
IBIO income_statement (annual, 2022-06-30) — Normalized EBITDA: -25722000.00
IBIO income_statement (annual, 2022-06-30) — Normalized Income: -29512000.00
IBIO cash_flow (annual, 2022-06-30) — Operating Cash Flow: -37480000.00
IBIO cash_flow (annual, 2022-06-30) — Operating Gains Losses: -607000.00
IBIO income_statement (annual, 2022-06-30) — Operating Income: -31453517.78
IBIO income_statement (annual, 2022-06-30) — Operating Revenue: 343482.22
IBIO balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 436357.00
IBIO balance_sheet (annual, 2022-06-30) — Other Current Assets: 1549000.00
IBIO balance_sheet (annual, 2022-06-30) — Other Current Liabilities: 56000.00
IBIO balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: -213000.00
IBIO income_statement (annual, 2022-06-30) — Other Gand A: 21754000.00
IBIO income_statement (annual, 2022-06-30) — Other Income Expense: 7000.00
IBIO balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 4851000.00
IBIO cash_flow (annual, 2022-06-30) — Other Non Cash Items: -52000.00
IBIO balance_sheet (annual, 2022-06-30) — Other Non Current Assets: 43310000.00
IBIO income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 7000.00
IBIO balance_sheet (annual, 2022-06-30) — Other Properties: 3068000.00
IBIO balance_sheet (annual, 2022-06-30) — Other Receivables: 5100000.00
IBIO balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 10845000.00
IBIO income_statement (annual, 2022-06-30) — Other Special Charges: -607000.00
IBIO balance_sheet (annual, 2022-06-30) — Payables: 4548000.00
IBIO balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 8028000.00
IBIO balance_sheet (annual, 2022-06-30) — Preferred Stock: 0.00
IBIO income_statement (annual, 2022-06-30) — Preferred Stock Dividends: 88000.00
IBIO cash_flow (annual, 2022-06-30) — Preferred Stock Issuance: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Prepaid Assets: 1549000.00
IBIO income_statement (annual, 2022-06-30) — Pretax Income: -29513000.00
IBIO cash_flow (annual, 2022-06-30) — Proceeds From Stock Option Exercised: 77000.00
IBIO balance_sheet (annual, 2022-06-30) — Properties: 0.00
IBIO cash_flow (annual, 2022-06-30) — Provisionand Write Offof Assets: 0.00